Fine particulate matter and cardiovascular disease

Fuel processing technology

Volumn 65, Issue , 2000, Pages 55-67

  Neas, Lucas M ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR QUALITY; CARDIOVASCULAR SYSTEM; HEALTH RISKS; IMPURITIES; PULMONARY DISEASES; TOXICITY;

CARDIOVASCULAR DISEASE; COPOLLUTANTS; MORTALITY;

PARTICLES (PARTICULATE MATTER);

EID: 0034205019     PISSN: 03783820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3820(99)00076-4     Document Type: Article

References (71)

1. U.S. Environmental Protection Agency, Office of Research and Development, Air Quality Criteria for Particulate Matter. Washington, DC, US Government Printing Office, 1997, EPA/600/P-95/001aF, Vol. III, pp. 12-31 to 12-75.
2. Schwartz J., Dockery D.W., Neas L.M. Is daily mortality associated specifically with fine particles? J. Air Waste Manage. Assoc. 46:1996;927-939.
3. U.S. Environmental Protection Agency, Air Quality Criteria for Particulate Matter, 1997, op cit., pp. 12-79 to 12-103.
4. Schwartz J., Morris R. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am. J. Epidemiol. 142:1995;23-35.
5. Burnett R.T., Dales R., Krewski D., Vincent R., Dann T., Brook J.R. Associations between ambient particle sulfate and admissions to Ontario hospitals for cardiac and respiratory diseases. Am. J. Epidemiol. 142:1995;15-22.
6. Pope C.A. 3rd, Thun M.J., Namboodiri M.M., Dockery D.W., Evans J.S., Speizer F.E., Heath C.W. Jr. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am. J. Respir. Crit. Care Med. 151:1995;669-674.
7. Moolgavkar S.H. Air pollution and mortality. N. Engl. J. Med. 330:1994;1237-1238. [letter].
8. Lipfert F.W., Wyzga R.E. Air pollution and mortality: issues and uncertainties. J. Air Waste Manage. Assoc. 45:1995;949-966.
9. National Research Council, Committee on Research Priorities for Airborne Particulate Matter, Research Priorities for Airborne Particulate Matter: I. Immediate Priorities and a Long-Range Research Portfolio, Washington, DC, National Academy Press, 1998.
10. Seaton A., MacNee W., Donaldson K., Godden D. Particulate air pollution and acute health effects. Lancet. 345:1995;176-178.
11. Oberdorster G., Ferin J., Lehnert B.E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102(Suppl. 5):1994;173-179.
12. Oberdorster G., Finkelstein J., Ferin J., Godleski J., Chang L.Y., Gelein R., Johnston C., Crapo J.D. Ultrafine particles as a potential environmental health hazard. Studies with model particles. Chest. 109:1996;68S-69S.
13. Peters A., Wichmann H.E., Tuch T., Heinrich J., Heyder J. Respiratory effects are associated with the number of ultrafine particles. Am. J. Respir. Crit. Care Med. 155:1997;1376-1383.
14. Murphy S.A., BeruBe K.A., Pooley F.D., Richards R.J. The response of lung epithelium to well characterized fine particles. Life Sci. 62:1998;1789-1799.
15. Zhang Q., Kusaka Y., Sato K., Nakakuki K., Kohyama N., Donaldson K. Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: role of free radicals. J. Toxicol. Environ. Health. 53:1998;423-438.
16. Kuschner W.G., Wong H., D'Alessandro A., Quinlan P., Blanc P.D. Human pulmonary responses to experimental inhalation of high concentration fine and ultrafine magnesium oxide particles. Environ. Health Perspect. 105:1997;1234-1237.
17. Lippmann M. Airborne acidity: estimates of exposure and human health effects. Environ. Health Perspect. 63:1985;63-70.
18. S.K. Friedlander, E.K. Yeh, The submicronic atmospheric aerosol as a carrier of reactive chemical species: case for peroxides, in: J. Lee, R. Phalen (Eds.), Proc. 2nd Colloq Particulate Air Pollution and Human Health, University Utah and Univ. California Press, Berkeley, CA, 1996, pp. 3-57.
19. .OH and produce hemolysis by acting as Fenton catalysts Arch. Biochem. Biophys. 269:1989;359-364.
20. Costa D.L., Dreher K.L. Bioavailable transition metals in particulate matter mediate cardiopulmonary injury in healthy and compromised animals. Environ. Health Perspect. 105(Suppl 5):1997;1053-1060.
21. Dreher K.L., Jaskot R.H., Lehmann J.R., Richards J.H., McGee J.K., Ghio A.J., Costa D.L. Soluble transition metals mediate residual oil fly ash induced acute lung injury. J. Toxicol. Environ. Health. 50:1997;285-305.
22. Kennedy T., Ghio A.J., Reed W., Samet J., Zagorski J., Quay J., Carter J., Dailey L., Hoidal J.R., Devlin R.B. Copper-dependent inflammation and nuclear factor-κB activation by particulate air pollution. Am. J. Respir. Cell Mol. Biol. 19:1998;366-378.
23. Vogelzang P.F., van der Gulden J.W., Folgering H., Kolk J.J., Heederik D., Preller L., Tielen M.J., van Schayck C.P. Endotoxin exposure as a major determinant of lung function decline in pig farmers. Am. J. Respir. Crit. Care Med. 157:1998;15-18.
24. Post W., Heederik D., Houba R. Decline in lung function related to exposure and selection processes among workers in the grain processing and animal feed industry. Occup. Environ. Med. 55:1998;349-355.
25. Jaskot R., Dreher K. Role of particle-associated endotoxin in ambient air particulate matter induced pulmonary inflammation. Am. J. Respir. Crit. Care Med. 155:1997;A248.
26. Platts-Mills T.A., Ward G.W. Jr., Sporik R., Gelber L.E., Chapman M.D., Heymann P.W. Epidemiology of the relationship between exposure to indoor allergens and asthma. Int. Arch. Allergy Appl. Immunol. 94:1991;339-345.
27. Carter J.D., Ghio A.J., Samet J.M., Reed W., Devlin R.B. In vitro exposure of human airway epithelial cells to an air pollution particle induces IL-6, IL-8 and TNFα protein expression. Am. J. Respir. Crit. Care Med. 155:1997;A246.
28. Sibille Y., Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:1990;471-501.
29. Agostini C., Chilosi M., Zambello R., Trentin L., Semenzato G. Pulmonary immune cells in health and disease: lymphocytes. Eur. Respir. J. 6:1993;1378-1401.
30. Sibille Y. Merchandise FX. Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur. Respir. J. 6:1993;1529-1543.
31. Staniford T.J., Kunkel S.L., Basha M.A., Chensue S.W., Lynch J.P. III, Toews G.B., Westwick J., Strieter R.M. Interleukin-8 gene expression by pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest. 86:1990;1945-1953.
32. Becker S., Koren H.S., Henke Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1 an interleukin-6. Am. J. Respir. Cell Mol. Biol. 8:1993;20-27.
33. Marini M., Vittori E., Hollemborg J., Mattoli S. Expression of potent inflammatory cytokines, granulocyte-macrophage colony stimulating factor, and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol. 89:1992;1001-1009.
34. Anwar A.R.F., Moqbel R., Walsh G.M., Kay A.B., Wardlaw A.J. Adhesion to fibronectin prolongs eosinophil survival. J. Exp. Med. 177:1993;839-843.
35. Salari H., Wong A. Generation of platelet activating factor (PAF) by a human epithelial cell line. Eur. J. Pharmacol. 175:1990;253-259.
36. Weisensee D., Bereiter-Hahn J., Schoeppe W., Low-Friedrich I. Effects of cytokines on the contractility of cultured cardiac myocytes. Int. J. Immunopharmacol. 15:1993;581-587.
37. Strieter R.M., Kunkel S.L., Bone R.C. Role of tumor necrosis factor-α in disease states and inflammation. Crit. Care Med. 21:1993;S447-S463.
38. Fuster V., Chesebro J.H. Antithrombotic therapy: role of platelet-inhibitor drugs: I. Current concepts of thrombogenesis: role of platelets. Mayo Clin. Proc. 56:1981;102-112.
39. Paton J.F.R. Pattern of cardiorespiratory afferent convergence to solitary tract neurons driven by pulmonary vagal c-fiber stimulation in the mouse. J. Neurophysiol. 79:1998;2365-2373.
40. Kannel W.B., Kannel C., Paffenbarger R.S. Jr., Cupples L.A. Heart rate and cardiovascular mortality: the Framingham study. Am. Heart J. 113:1987;1489-1494.
41. Tsuji H., Larson M.G., Venditti F.J. Jr., Manders E.S., Evans J.C., Feldman C.L., Levy D. Impact of reduced heart rate variability on risk for cardiac events. Circulation. 94:1996;2850-2855.
42. Tsuji H., Venditti F.J. Jr., Manders E.S., Evans J.C., Larson M.G., Feldman C.L., Levy D. Reduced heart rate variability and mortality risk in an elderly cohort. Circulation. 90:1994;878-883.
43. Peters A., Doering A., Wichmann H.-E., Koenig W. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet. 349:1997;1582.
44. Chapman R.S., Watkinson W.P., Dreher K.L., Costa D.L. Ambient particulate matter and respiratory and cardiovascular illness in adults: particle-borne transition metals and the heart-lung axis. Environ. Toxicol. Pharmacol. 4:1997;331-338.
45. Watkinson W.P., Campen M.J., Costa D.L. Cardiac arrhythmia induction after exposure to residual oil fly ash particles in a rodent model of pulmonary hypertension. Toxicol. Sci. 41:1998;209-216.
46. Sioutas C., Koutrakis P., Burton R.M. A technique to expose animals to concentrated fine ambient aerosols. Environ. Health Perspect. 103:1995;172-177.
47. Clarke R.W., Hatch V., Katler M., Koutrakis P., Love J., Krishna Murthy G.G., Stearns R., Sioutas C., Paulauskis J., Godleski J.J. Concentrated urban air particulate (CAPS) inhalation induces pulmonary inflammation in normal and chronic bronchitic rats. Am. J. Respir. Crit. Care Med. 157:1998;A151.
48. Clarke R.W., Catalano P., Krishna Murthy G.G., Sioutas C., Wolfson M., Koutrakis P., Godleski J.J. Inhalation of concentrated ambient air particulate (CAPS) induces pulmonary function alterations in normal and chronic bronchitic rats. Am. J. Respir. Crit. Care Med. 157:1998;A153.
49. J.J. Godleski, C. Sioutas, M. Katler, M. Catalano, P. Koutrakis, Death from inhalation of concentrated ambient air particles in animal models of pulmonary disease, in: J. Lee, R. Phalen (Eds.), Proc. 2nd Colloq Particulate Air Pollution and Human Health, University Utah and Univ. California Press, Berkeley, CA, pp. 4-136.
50. Nearing B.D., Verrier R.L., Skornick W.A., Gazula G., Killingsworth C.R., Oakberg K., Godleski J.J. Inhaled fly ash results in alteration in cardiac electrophysiologic function. Am. J. Respir. Crit. Care Med. 153:1996;A543.
51. Godleski J.J., Sioutas C., Verrier R.L., Killingsworth C.R., Lovett E.G., Krishna Murthy G.G., Hatch V., Wolfson J.M., Ferguson S.T., Koutrakis P. Inhalation exposure of canines to concentrated air particles. Am. J. Respir. Crit. Care Med. 155:1997;A246.
52. Lovett E.G., Verrier R.L., Catalano P., Sioutas C., Krishna Murthy G.G., Wolfson J.M., Ferguson S.T., Koutrakis P., Reinisch U., Killingsworth C.R., Coull B., Godleski J.J. Heart rate variability (HRV) analysis suggests altered autonomic influence in canines exposed to concentrated ambient air particles (CAPs). Am. J. Respir. Crit. Care Med. 157:1998;A260.
53. Health Effects Institute, Fall 1998 Research Agenda, Cambridge, MA, 1998.
54. U.S. Environmental Protection Agency, Interagency agreement between the U.S. Environmental Protection Agency Office of Research and Development and the U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Human Studies Division, 1998, Research Triangle Park, NC.
55. Pope C.A. III, Dockery D.W., Kanner R.E., Villegas G.M., Schwartz J. Oxygen saturation, pulse rate, and particulate air pollution. Am. J. Respir. Crit. Care Med. 159:1999;365-372.
56. Gold D.R., Litonjua A., Schwartz J., Verrier M., Milstein R., Larson A., Lovett E.G., Verrier R. Cardiovascular vulnerability to particulate pollution. Am. J. Respir. Crit. Care Med. 157:1998;A261.
57. Liao D., Creason J., Shy C., Williams R., Watts R., Zweidinger R. Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ. Health Perspect. 107:1999;521-525.
58. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 93:1996;1043-1065.
59. Van Lommel A., Lauweryns J.M., Berthoud H.R. Pulmonary neuroepithelial bodies are innervated by vagal afferent nerves: an investigation with in vivo anterograde DiI tracing and confocal microscopy. Anat. Embryol. 197:1998;325-330.
60. Lai C.J., Kou Y.R. Stimulation of vagal pulmonary C fibers by inhaled wood smoke in rats. J. Appl. Physiol. 84:1998;30-36.
61. Matsumoto S., Kanno T., Yamasaki M., Nagayama T., Shimizu T. Pulmonary C-fibers elicit both apneusis and tachypnea in the rabbit. Respir. Physiol. 87:1992;165-181.
62. Wolf M.M., Varigos G.A., Hunt D., Sloman J.G. Sinus arrhythmia in acute myocardial infarction. Med. J. Aust. 2:1978;52-53.
63. Odemuyiwa O., Malik M., Farrell T., Bashir Y., Poloniecki J., Camm J. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am. J. Cardiol. 68:1991;434-439.
64. Kienzle M.G., Ferguson D.W., Birkett C.L., Myers G.A., Berg W.J., Mariano D.J. Clinical hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am. J. Cardiol. 69:1992;482-485.
65. Tsuji H., Larson M.G., Venditti F.J., Manders E.S., Evans J.C., Feldman C.L., Levy D. Impact of reduced heart rate variability on rick for cardiac events. The Framingham Heart Study. Circulation. 94:1996;2850-2855.
66. J. Creason, R. Williams, Protocol for a study of physiological effects of ambient air particles on elderly residents of retirement communities in the presence of co-pollutants, National Health and Environmental Effects Research Laboratory, Human Studies Division, 1998, Research Triangle Park, NC.
67. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am. J. Epidemiol. 133:1991;144-153.
68. Mittleman M.A., Maclure M., Nachnani M., Sherwood J.B., Muller J.E. Educational attainment, anger, and the risk of triggering myocardial infarction onset. Arch. Intern. Med. 157:1997;769-775.
69. Navidi W. Bidirectional case-crossover designs for exposures with time trends. Biometrics. 54:1998;596-605.
70. Meier C.R., Jick S.S., Derby L.E., Vasilakis C., Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 351(9114):1998;1467-1471.
71. H. Checkoway, J. Kaufman, J. Koenig, E. Sheppard, D. Levy, D. Siscovick, Case-crossover study of particulate air pollution and primary cardiac arrest: study design and methods, Poster presentation at the 13th Health Effects Institute Annual Conference, Annapolis, MD, May 1997.